Cyclosporiasis: Investing in Biosecurity

Recent outbreaks, including cyclosporiasis linked to contaminated Mexican iceberg lettuce, highlight the vulnerability of supply chains and underscore the importance of biosecurity. The global food safety testing market is projected to grow significantly, from $28.1 billion in 2026 to $52.9 billion by 2034. This trend benefits companies within the ROBO Global Healthcare Technology and Innovation (HTEC) index, particularly in its diagnostics and process automation subsegments.

Diagnostics companies are leveraging multiplex PCR platforms for rapid, simultaneous screening of multiple pathogens, replacing slower traditional methods and generating recurring revenue through testing kits. Companies like QIAGEN (QGEN), Danaher (DHR), Bio-Rad (BIO), and Thermo Fisher (TMO) provide foundational technologies for pathogen detection. The economic model relies on the sale of proprietary consumables for installed instrumentation.

In the process automation sector, companies are integrating high-throughput screening and rapid immunoassays into agricultural workflows to help food producers meet regulatory requirements and reduce recall risks. Eurofins Scientific (ERF) and Thermo Fisher are key players in this area, addressing the challenges of detecting microscopic parasites and bacteria in fresh produce without causing significant delays or false positives. These technological advancements are crucial for maintaining food safety and mitigating the impact of foodborne threats.